Integrated device intended for at-home molecular testing (IMAGE)
Caption
3EO Health licensed diagnostic technology from Harvard that was developed and prototyped at the Wyss Institute to enable at-home molecular testing with PCR-grade sensitivity and antigen test-level cost. The optimized device shown here allows users to perform an innovative molecular assay detecting SARS-CoV-2 or other pathogens with high speed, sensitivity, and specificity with minimal input at home. It functions as a re-usable base unit that carries out the assay with pathogen-specific, one-time-use consumables.
Credit
3EO Health, Inc.
Usage Restrictions
Please connect to 3EO Health Inc. for further use of the image.
License
Original content